Association of TLR2 and TLR4 polymorphisms with risk of cancer: A meta-analysis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Zhu, Longbiao ^a   Yuan, Hua ^a   Jiang, Tao ^a   Wang, Ruixia ^a   Ma, Hongxia ^a   Zhang, Shuangyue ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; GENETIC ASSOCIATION; HUMAN; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; TOLL LIKE RECEPTOR 2 GENE; TOLL LIKE RECEPTOR 4 GENE;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; DIGESTIVE SYSTEM NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84893369105     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082858     Document Type: Article

References (64)

1. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
2. Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science 327: 291-295.
3. Wang RF, Miyahara Y, Wang HY (2008) Toll-like receptors and immune regulation: implications for cancer therapy. Oncogene 27: 181-189.
4. Basith S, Manavalan B, Yoo TH, Kim SG, Choi S (2012) Roles of toll-like receptors in cancer: a double-edged sword for defense and offense. Arch Pharm Res 35: 1297-1316.
5. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21: 335-376. (Pubitemid 37174535)
6. Aderem A, Ulevitch RJ (2000) Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787.
7. Drexler SK, Foxwell BM (2010) The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol 42: 506-518.
8. Menendez D, Shatz M, Azzam K, Garantziotis S, Fessler MB, et al. (2011) The Toll-like receptor gene family is integrated into human DNA damage and p53 networks. PLoS Genet 7: e1001360.
9. Harberts E, Gaspari AA (2013) TLR signaling and DNA repair: are they associated? J Invest Dermatol 133: 296-302.
10. Kagan JC, Su T, Horng T, Chow A, Akira S, et al. (2008) TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 9: 361-368. (Pubitemid 351405105)
11. Sabroe I, Dower SK, Whyte MK (2005) The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clin Infect Dis 41 Suppl 7: S421-426. (Pubitemid 41598299)
12. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, et al. (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11: 443-451. (Pubitemid 29504199)
13. Huang B, Zhao J, Shen S, Li H, He KL, et al. (2007) Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. Cancer Res 67: 4346-4352. (Pubitemid 46815083)
14. Chen R, Alvero AB, Silasi DA, Steffensen KD, Mor G (2008) Cancers take their Toll - the function and regulation of Toll-like receptors in cancer cells. Oncogene 27: 225-233.
15. He W, Liu Q, Wang L, Chen W, Li N, et al. (2007) TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 44: 2850-2859. (Pubitemid 46412506)
16. Wang JH, Manning BJ, Wu QD, Blankson S, Bouchier-Hayes D, et al. (2003) Endotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanism. J Immunol 170: 795-804. (Pubitemid 36070531)
17. Ahmed A, Wang JH, Redmond HP (2012) Silencing of TLR4 Increases Tumor Progression and Lung Metastasis in a Murine Model of Breast Cancer. Ann Surg Oncol.
18. Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, et al. (2008) Functional consequences of toll-like receptor 4 polymorphisms. Mol Med 14: 346-352. (Pubitemid 351785708)
19. Singh V, Srivastava N, Kapoor R, Mittal RD (2013) Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in a case-control study with bladder cancer susceptibility in a North Indian population. Arch Med Res 44: 54-61.
20. Shen Y, Liu Y, Liu S, Zhang A (2013) Toll-like receptor 4 gene polymorphisms and susceptibility to bladder cancer. Pathol Oncol Res 19: 275-280.
21. Theodoropoulos GE, Saridakis V, Karantanos T, Michalopoulos NV, Zagouri F, et al. (2012) Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development. Breast 21: 534-538.
22. Etokebe GE, Knezevic J, Petricevic B, Pavelic J, Vrbanec D, et al. (2009) Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in case-control study with breast cancer. Genet Test Mol Biomarkers 13: 729-734.
23. de Oliveira JG, Silva AE (2012) Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population. World J Gastroenterol 18: 1235-1242.
24. Zeng HM, Pan KF, Zhang Y, Zhang L, Ma JL, et al. (2011) Genetic variants of toll-like receptor 2 and 5, helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population. Cancer Epidemiol Biomarkers Prev 20: 2594-2602.
25. Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, et al. (2010) No associations of Toll-like receptor 2 (TLR2) -196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese. Gastric Cancer 13: 251-257.
26. Trejo-de la OA, Torres J, Perez-Rodriguez M, Camorlinga-Ponce M, Luna LF, et al. (2008) TLR4 single-nucleotide polymorphisms alter mucosal cytokine and chemokine patterns in Mexican patients with Helicobacter pylori-associated gastroduodenal diseases. Clin Immunol 129: 333-340.
27. Santini D, Angeletti S, Ruzzo A, Dicuonzo G, Galluzzo S, et al. (2008) Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes. Clin Exp Immunol 154: 360-364.
28. Garza-Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI, Flores-Gutierrez JP, Maldonado-Garza HJ, et al. (2007) Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8-251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer 7: 70.
29. Rigoli L, Di Bella C, Fedele F, Procopio V, Amorini M, et al. (2010) TLR4 and NOD2/CARD15 genetic polymorphisms and their possible role in gastric carcinogenesis. Anticancer Res 30: 513-517.
30. Tahara T, Arisawa T, Wang F, Shibata T, Nakamura M, et al. (2007) Toll-like receptor 2-196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer. Cancer Sci 98: 1790-1794. (Pubitemid 47487917)
31. Hold GL, Rabkin CS, Chow WH, Smith MG, Gammon MD, et al. (2007) A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 132: 905-912. (Pubitemid 46440859)
32. Mandal RK, George GP, Mittal RD (2012) Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population. Mol Biol Rep 39: 7263-7269.
33. Balistreri CR, Caruso C, Carruba G, Miceli V, Campisi I, et al. (2010) A pilot study on prostate cancer risk and pro-inflammatory genotypes: pathophysiology and therapeutic implications. Curr Pharm Des 16: 718-724.
34. Wang MH, Helzlsouer KJ, Smith MW, Hoffman-Bolton JA, Clipp SL, et al. (2009) Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate 69: 874-885.
35. Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, et al. (2005) Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res 65: 11771-11778. (Pubitemid 41821739)
36. Zheng SL, Augustsson-Balter K, Chang B, Hedelin M, Li L, et al. (2004) Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. Cancer Res 64: 2918-2922. (Pubitemid 38500633)
37. Cheng I, Plummer SJ, Casey G, Witte JS (2007) Toll-like receptor 4 genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev 16: 352-355. (Pubitemid 46383358)
38. Nischalke HD, Coenen M, Berger C, Aldenhoff K, Muller T, et al. (2012) The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C. Int J Cancer 130: 1470-1475.
39. Agundez JA, Garcia-Martin E, Devesa MJ, Carballo M, Martinez C, et al. (2012) Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma. Oncology 82: 35-40.
40. Srivastava K, Srivastava A, Kumar A, Mittal B (2010) Significant association between toll-like receptor gene polymorphisms and gallbladder cancer. Liver Int 30: 1067-1072.
41. Pandey S, Mittal RD, Srivastava M, Srivastava K, Singh S, et al. (2009) Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women. Gynecol Oncol 114: 501-505.
42. Yang ZH, Dai Q, Gu YJ, Guo QX, Gong L (2012) Cytokine and chemokine modification by Toll-like receptor polymorphisms is associated with nasopharyngeal carcinoma. Cancer Sci 103: 653-658.
43. Miedema KG, Tissing WJ, Te Poele EM, Kamps WA, Alizadeh BZ, et al. (2012) Polymorphisms in the TLR6 gene associated with the inverse association between childhood acute lymphoblastic leukemia and atopic disease. Leukemia 26: 1203-1210.
44. Gast A, Bermejo JL, Claus R, Brandt A, Weires M, et al. (2011) Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival. PLoS One 6: e24370.
45. Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, et al. (2010) Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk. BMC Cancer 10: 382.
46. Purdue MP, Lan Q, Wang SS, Kricker A, Menashe I, et al. (2009) A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis 30: 275-281.
47. Nieters A, Beckmann L, Deeg E, Becker N (2006) Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. Genes Immun 7: 615-624. (Pubitemid 46242365)
48. Ture-Ozdemir F, Gazouli M, Tzivras M, Panagos C, Bovaretos N, et al. (2008) Association of polymorphisms of NOD2, TLR4 and CD14 genes with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Anticancer Res 28: 3697-3700.
49. Forrest MS, Skibola CF, Lightfoot TJ, Bracci PM, Willett EV, et al. (2006) Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma. Br J Haematol 134: 180-183. (Pubitemid 43893909)
50. Hellmig S, Fischbach W, Goebeler-Kolve ME, Folsch UR, Hampe J, et al. (2005) Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma 46: 869-872. (Pubitemid 40965398)
51. Boraska Jelavic T, Barisic M, Drmic Hofman I, Boraska V, Vrdoljak E, et al. (2006) Microsatelite GT polymorphism in the toll-like receptor 2 is associated with colorectal cancer. Clin Genet 70: 156-160. (Pubitemid 44028102)
52. Landi S, Gemignani F, Bottari F, Gioia-Patricola L, Guino E, et al. (2006) Polymorphisms within inflammatory genes and colorectal cancer. J Negat Results Biomed 5: 15.
53. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826. (Pubitemid 27465551)
54. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
55. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
56. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
57. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, et al. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187-191. (Pubitemid 30394990)
58. Lindstrom S, Hunter DJ, Gronberg H, Stattin P, Wiklund F, et al. (2010) Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies. Cancer Epidemiol Biomarkers Prev 19: 873-876.
59. Castano-Rodriguez N, Kaakoush NO, Goh KL, Fock KM, Mitchell HM (2013) The role of TLR2, TLR4 and CD14 genetic polymorphisms in gastric carcinogenesis: a case-control study and meta-analysis. PLoS One 8: e60327.
60. Zhang K, Zhou B, Wang Y, Rao L, Zhang L (2013) The TLR4 gene polymorphisms and susceptibility to cancer: a systematic review and meta-analysis. Eur J Cancer 49: 946-954.
61. Su B, Ceponis PJ, Lebel S, Huynh H, Sherman PM (2003) Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect Immun 71: 3496-3502. (Pubitemid 36637578)
62. Wroblewski LE, Peek RM, Jr. (2013) Helicobacter pylori in gastric carcinogenesis: mechanisms. Gastroenterol Clin North Am 42: 285-298.
63. Liu L, Wu C, Wang Y, Zhong R, Wang F, et al. (2011) Association of candidate genetic variations with gastric cardia adenocarcinoma in Chinese population: a multiple interaction analysis. Carcinogenesis 32: 336-342.
64. Zhong R, Liu L, Zou L, Sheng W, Zhu B, et al. (2013) Genetic variations in the TGFbeta signaling pathway, smoking and risk of colorectal cancer in a Chinese population. Carcinogenesis 34: 936-942.